When to Call vs. When to Wait: A Symptom Triage Chart for GLP-1 Patients
Updated September 2026 · Medically reviewed content · 10 min read
Not every symptom on a GLP-1 medication is a crisis, but not every symptom is harmless either. The challenge for patients — especially in the early weeks — is knowing the difference. This triage chart sorts the most common side effects and symptoms into three categories based on what clinicians would actually recommend if you called their office.
How to use this guide: Find your symptom, check the color level, and follow the guidance. Green means monitor at home. Amber means contact your prescriber within 24–48 hours. Red means act now — same-day contact or emergency care depending on severity.
Green Zone: Monitor at Home
These symptoms are common, expected, and documented in clinical trial data. They typically resolve on their own within days to weeks and do not indicate a problem with the medication or your health.
Mild nausea (no vomiting)
Reported by 15–44% of GLP-1 patients across trial data, depending on dose. Most common in the first 1–3 days after each injection, especially during titration. It's caused by delayed gastric emptying and central nervous system effects on appetite pathways.
What to do: Eat small, frequent meals. Avoid high-fat and greasy foods. Ginger tea or ginger chews can help. Stay upright after eating. If you find a pattern (worse on injection day, better by day 3), that's normal cyclical nausea that tends to improve over 4–8 weeks.
Reduced appetite or "food noise" disappearing
This is the medication working as intended, not a side effect. The distinction matters: reduced appetite means you get full faster and think about food less. Not eating at all is a problem — see the amber section below.
What to do: Eat on a schedule even when you don't feel hungry. Prioritize protein (60–80g/day minimum). Set alarms if you tend to forget meals. Your body still needs nutrition even when your brain says it doesn't.
Mild constipation
Occurs in 10–25% of patients. Slowed GI transit is a direct mechanism of GLP-1 receptor agonists. Most patients experience mild, manageable changes in bowel habits rather than complete obstruction.
What to do: Increase water intake to 80+ ounces per day. Add fiber gradually (25–30g/day from food, or a fiber supplement). Walk for 15–20 minutes daily. If three days pass without a bowel movement, start an osmotic laxative (polyethylene glycol/MiraLAX) as a first-line intervention.
Mild headache
Reported in 10–14% of patients, almost always dehydration-related. More common in the first two weeks and during dose increases.
What to do: Drink more water. Acetaminophen (Tylenol) is safe and effective. Avoid NSAIDs (ibuprofen, naproxen) if you're not well-hydrated — the combination of GLP-1-related dehydration and NSAIDs can strain kidneys.
Injection site reaction (small, localized)
A pink mark, small bump, or mild itching at the injection site is a normal local tissue reaction. It typically resolves within 24–48 hours.
What to do: Rotate injection sites (abdomen, thigh, or upper arm). Allow cold medication to warm to room temperature before injecting. A cool compress can relieve itching. If the reaction area stays smaller than a quarter, this is green-zone.
Fatigue in the first week
About 5–10% of patients report unusual tiredness early in treatment. In most cases, this traces to reduced caloric intake — your body notices the calorie deficit before you consciously register that you're eating less.
What to do: Ensure you're eating enough. Track calories for a few days to check. Adequate protein and complex carbohydrates will usually resolve this. If fatigue persists beyond week two despite adequate nutrition, move to amber.
Sulfur burps or increased gas
Sulfur-tasting belching is reported by a meaningful minority of patients and is related to delayed gastric emptying. Food sitting in the stomach longer produces more gas. It's unpleasant but not dangerous.
What to do: Eat slowly. Avoid cruciferous vegetables (broccoli, cauliflower, cabbage), carbonated drinks, and high-sulfur foods during flare-ups. Simethicone (Gas-X) can provide relief. This tends to improve as your body adapts.
Amber Zone: Contact Your Prescriber Within 24–48 Hours
These symptoms require professional evaluation but are not emergencies. Most can be managed with a dosing adjustment, a prescription change, or clinical guidance. Call your provider's office, send a portal message, or schedule a telehealth follow-up.
Nausea that worsens after 72 hours instead of improving
The expected trajectory of GLP-1-related nausea is: appears in the first 24–48 hours → peaks → begins improving by days 3–5. If nausea is getting progressively worse after 72 hours, your provider may need to adjust your titration schedule, add an antiemetic, or evaluate for other causes.
What to tell your provider: When it started, the trajectory (better/worse/stable), whether you can keep food and liquids down, and whether it's associated with specific foods or times of day.
Inability to eat more than a few bites per meal for more than 3 days
Severe appetite suppression on a starting dose can lead to dangerous caloric deficits. If you're consistently consuming fewer than 800 calories per day and cannot increase intake despite trying, this needs clinical attention. Prolonged under-eating causes muscle catabolism, electrolyte disturbances, and metabolic complications.
What to tell your provider: Approximate daily calorie and protein intake, number of meals attempted, and whether the barrier is nausea, early satiety, or complete absence of hunger.
Constipation lasting more than 5 days despite intervention
If three or more days have passed without a bowel movement, you've tried adequate hydration, fiber, and an osmotic laxative, and there's still no resolution — contact your prescriber. Severe constipation on GLP-1s can, in rare cases, progress to bowel obstruction, which is a medical emergency. The amber-zone intervention is intended to prevent that escalation.
Dizziness when standing up
Orthostatic dizziness (feeling lightheaded when you stand from sitting or lying) can indicate dehydration or, less commonly, low blood pressure from caloric restriction. If it's happening more than occasionally and doesn't resolve with increased fluid intake, your provider should check your blood pressure and possibly your blood glucose.
Hair shedding that's noticeable
Hair loss on GLP-1 therapy is usually telogen effluvium — a temporary shedding triggered by rapid weight loss, caloric deficit, or nutritional deficiency. It typically begins 2–4 months after starting and resolves on its own within 6–12 months. Your provider should evaluate nutritional status (especially iron, ferritin, zinc, biotin, and protein intake) and may slow your rate of weight loss.
Significant mood changes
Post-market surveillance and patient-reported data have flagged mood changes — particularly depressed mood, anxiety, or irritability — in some GLP-1 patients. The mechanism is not fully established, but rapid caloric shifts, hormonal changes from fat-mass loss, and disruption to the gut-brain axis are all plausible. Your prescriber should evaluate this, especially if you have a history of mood disorders.
Injection site reactions that expand beyond a quarter-size area
A reaction that spreads beyond the immediate injection site, persists longer than 48 hours, or becomes warm to the touch warrants evaluation. This could indicate a local infection, a more significant allergic response, or an issue with injection technique.
Need a provider who offers easy check-in access?
Embody includes provider messaging during treatment. Injectable semaglutide from $69–99 first month (ongoing ~$299/mo).
Check Embody Availability →Compounded semaglutide injection — not FDA-approved. Embody offers injectable semaglutide only.
Red Zone: Act Now
These symptoms are rare at any dose but require immediate medical attention. Do not wait for a callback or an appointment. If you cannot reach your prescriber, go to an urgent care clinic or emergency department.
Persistent vomiting (unable to keep liquids down for 12+ hours)
Intractable vomiting on a GLP-1 is uncommon at starting doses but can occur, particularly if gastroparesis is pre-existing. If you cannot keep water, broth, or electrolyte solution down for more than 12 hours, you risk severe dehydration and electrolyte imbalances. This is a same-day medical evaluation, not a "wait until Monday" situation.
Severe, constant abdominal pain radiating to the back
This is the classic presentation of acute pancreatitis. GLP-1 receptor agonists carry a known (though uncommon) association with pancreatitis. The pain is typically in the upper abdomen, steady (not crampy), and often radiates to the back. It may worsen after eating. If this describes what you're feeling, seek emergency evaluation with lipase blood testing. Do not take another dose until cleared by a physician.
Signs of allergic reaction: hives, facial swelling, difficulty breathing
True anaphylaxis to GLP-1 receptor agonists is extremely rare but is listed in prescribing information. If you develop hives (raised, itchy welts spreading across your body), swelling of the face, lips, tongue, or throat, or any difficulty breathing — this is a 911 call. Do not drive yourself. Use epinephrine (EpiPen) if you have one and have been instructed in its use.
Severe hypoglycemia symptoms (confusion, slurred speech, loss of consciousness)
GLP-1 medications alone rarely cause dangerous hypoglycemia because their insulin-stimulating effect is glucose-dependent. However, if you're also taking insulin, a sulfonylurea, or another glucose-lowering medication, the combination can drop blood sugar dangerously. Confusion, trembling, cold sweats, slurred speech, or loss of consciousness in a diabetic patient on combination therapy is a medical emergency. Administer oral glucose if the person is conscious, and call 911 if they lose consciousness.
Signs of bowel obstruction: complete inability to pass gas or stool, distended abdomen, severe cramping
This is rare and almost never occurs at starting doses, but severe GLP-1-mediated slowing of GI transit can, in predisposed patients, progress from constipation to functional obstruction. If you have zero bowel movements for 7+ days, cannot pass gas, have a visibly distended (swollen) abdomen, and are experiencing severe cramping — seek emergency evaluation with abdominal imaging.
Thyroid lump or persistent difficulty swallowing
Both semaglutide and tirzepatide carry a boxed warning about thyroid C-cell tumors observed in rodent studies. The relevance to humans is not established, but any new lump in the front of your neck, persistent hoarseness, or difficulty swallowing should be evaluated promptly with a thyroid examination and possibly ultrasound. This applies for the duration of GLP-1 therapy, not just the first 72 hours.
Special Situations
If you're diabetic and on other medications
GLP-1 receptor agonists amplify the glucose-lowering effects of insulin and sulfonylureas. Your prescriber should have adjusted these doses when starting your GLP-1, but blood sugar can still drop lower than expected in the first days. Monitor more frequently — at least 4 times per day in the first week — and know your prescriber's standing orders for dose adjustments based on your readings.
If you're about to have surgery or a procedure
The American Society of Anesthesiologists issued updated guidance in 2024 recommending that GLP-1 medications be held before procedures requiring sedation or general anesthesia due to the risk of residual gastric contents and aspiration. If you have a scheduled procedure within the next 1–3 weeks, inform both your prescriber and your surgical/anesthesia team immediately. Do not assume they already know you've started a GLP-1.
If you recently started or changed birth control
Tirzepatide specifically has labeling noting potential changes in oral contraceptive absorption due to delayed gastric emptying. If you're on oral birth control and starting tirzepatide, discuss backup contraception with your prescriber during the first 4 weeks and for 4 weeks after each dose increase.
GobyMeds: No-commitment GLP-1 — free consult included
Compounded semaglutide from $99/mo (12-week bundle). No subscription, no auto-renew. Overnight refrigerated shipping.
See GobyMeds Plans →Compounded medication — not FDA-approved. Dispensed by licensed 503A pharmacies.
A Note on Timing
This triage chart applies to any point during GLP-1 therapy, not just the first 72 hours. Save or bookmark this page. Titration days — when your dose increases — often produce a mild repeat of the initial adjustment period, and having a quick reference for which symptoms are green, amber, or red prevents both unnecessary anxiety and dangerous delays in seeking care.
If you're ever genuinely unsure which category your symptom falls into, default to amber and contact your prescriber. No clinician has ever been upset by a cautious patient asking a reasonable question.